FDA OKs Agfa IMPAX mammography workstation
Agfa Corp. has received U.S. Food and Drug Administration clearance for its IMPAX mammography diagnostic workstation.
The multimodality workstation is designed for the retrieval, display, archival and distribution of mammography images. Agfa said the IMPAX mammography workstation is cleared as a vendor-neutral system for regionally approved digital mammography modality vendors.
Incorporating high-resolution monitors for softcopy diagnosis of breast images, Agfa said the workstation is equipped with image manipulation tools such as window/level, invert, zoom, magnify, annotation, hanging protocols, and study management tools such as priors handling, active worklist and routing rules. The workstation also comes with full integration capability with information systems such as PACS, RIS and HIS as well as reporting applications.
The multimodality workstation is designed for the retrieval, display, archival and distribution of mammography images. Agfa said the IMPAX mammography workstation is cleared as a vendor-neutral system for regionally approved digital mammography modality vendors.
Incorporating high-resolution monitors for softcopy diagnosis of breast images, Agfa said the workstation is equipped with image manipulation tools such as window/level, invert, zoom, magnify, annotation, hanging protocols, and study management tools such as priors handling, active worklist and routing rules. The workstation also comes with full integration capability with information systems such as PACS, RIS and HIS as well as reporting applications.